Belvedere Trading
DGX icon

Belvedere Trading’s Quest Diagnostics DGX Stock Holding History

Belvedere Trading’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,240
Closed -$217K – 102
2014
Q4 		$217K Buy
+3,240
New +$204K ﹤0.01% 411

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Belvedere Trading's DGX Position: Q1 2015 in Review

Belvedere Trading sold out of Quest Diagnostics (DGX) in Q1 2015, closing a stake of 3,240 shares — an estimated $217K sold.

Belvedere Trading first reported a position in DGX in Q4 2014 and held it in 1 quarter. The position peaked at $217K in Q4 2014. 553 funds tracked by Wall St. Rank hold DGX as of Q1 2015.

  • Belvedere Trading reported no remaining Quest Diagnostics position as of Q1 2015 after selling out during the quarter.
  • Belvedere Trading sold 3,240 Quest Diagnostics shares in Q1 2015, an estimated $217K.
  • Belvedere Trading first reported a position in Quest Diagnostics in Q4 2014 and held it in 1 quarter.
  • Belvedere Trading's Quest Diagnostics position peaked at $217K in Q4 2014.
  • 553 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2015.

Based on Belvedere Trading's 13F filing for Q1 2015, filed 14 May 2015.